|
|
|
Volumn 59, Issue 2, 2001, Pages 323-327
|
|
A strategy for second-line anti-Helicobacter pylori therapy in patients with previously failed treatment
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE;
AMOXICILLIN;
CLARITHROMYCIN;
CYP2C19 PROTEIN, HUMAN;
CYTOCHROME P450;
DRUG DERIVATIVE;
ENZYME INHIBITOR;
LANSOPRAZOLE;
METRONIDAZOLE;
MIXED FUNCTION OXIDASE;
OMEPRAZOLE;
PROTON PUMP;
UNSPECIFIC MONOOXYGENASE;
DRUG ANTAGONISM;
DRUG COMBINATION;
GENETIC POLYMORPHISM;
GENETICS;
HELICOBACTER INFECTION;
HELICOBACTER PYLORI;
HUMAN;
PATIENT COMPLIANCE;
REVIEW;
TREATMENT FAILURE;
2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES;
AMOXICILLIN;
ARYL HYDROCARBON HYDROXYLASES;
CLARITHROMYCIN;
CYTOCHROME P-450 ENZYME SYSTEM;
DRUG THERAPY, COMBINATION;
ENZYME INHIBITORS;
HELICOBACTER INFECTIONS;
HELICOBACTER PYLORI;
HUMANS;
METRONIDAZOLE;
MIXED FUNCTION OXYGENASES;
OMEPRAZOLE;
PATIENT COMPLIANCE;
POLYMORPHISM, GENETIC;
PROTON PUMPS;
TREATMENT FAILURE;
|
|
EID: 0035259402
PISSN: 00471852
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (1)
|
|
References (13)
|
